COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
发明人:
Franck Mouthon,Matthieu Charveriat
申请号：
US14890984
公开号：
US20160082016A1
申请日:
2014.05.14
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to the use of a well-known benzodiazepine compound, namely clonazepam, in combination with antibiotic agents, for treating bacterially induced meningitis.
